GNH USA

Europe — EMA

Jivi (Damoctocog Alfa Pegol)

GNH USA supplies Jivi (Damoctocog Alfa Pegol), a recombinant factor VIII product for prophylaxis and treatment of bleeding in hemophilia A. Request a quote.

Damoctocog Alfa Pegol

Request sourcing

1
Pack/s

What is Damoctocog Alfa Pegol?

Damoctocog alfa pegol, the active ingredient in Jivi, is a recombinant factor VIII product presented as a solution for injection for intravenous use. It replaces the deficient clotting factor in patients with hemophilia A, helping to control and prevent bleeding episodes.

GNH USA supplies Jivi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Damoctocog Alfa Pegol used for?

Jivi is a recombinant factor VIII therapy used within the hemophilia A treatment pathway.

Prophylaxis: reduces the frequency of spontaneous bleeding episodes in patients with hemophilia A. Acute Bleeding Treatment: controls and stops active bleeding episodes in hemophilia A patients. Surgical Coverage: provides hemostatic support during surgical procedures for individuals with hemophilia A.

What are the side effects of Damoctocog Alfa Pegol?

Jivi may be associated with several adverse reactions.

Common Side Effects: - Injection site pain or erythema - Headache - Fever or chills - Arthralgia - Nausea - Fatigue

Serious or Rare Side Effects: - Development of inhibitory antibodies against factor VIII - Anaphylactic or severe hypersensitivity reactions - Thromboembolic events - Severe hemolysis - Disseminated intravascular coagulation (DIC)

What precautions apply to Damoctocog Alfa Pegol?

When using Jivi, certain precautions should be observed. - Individualized Dosing: dosing must be determined by a qualified prescriber based on patient-specific factors. - Inhibitor Monitoring: regularly assess for development of factor VIII inhibitors. - Hypersensitivity: avoid in patients with known allergy to the product or its excipients. - Concomitant Anticoagulants: use caution if the patient is receiving other anticoagulant therapies. - Renal/Hepatic Function: evaluate organ function before initiating therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

What does Damoctocog Alfa Pegol interact with?

Jivi can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Concurrent use with other factor VIII concentrates may increase inhibitor risk. - Simultaneous administration with high‑dose anticoagulants can compromise hemostasis.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., aminoglycosides) may interfere with clotting assays. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) may elevate bleeding tendency. - Immunosuppressive agents could affect inhibitor development monitoring.

Frequently asked questions

What is Jivi used for?+
Jivi is used as a replacement therapy for patients with hemophilia A. It provides the missing factor VIII to help prevent and control bleeding episodes, both in routine prophylaxis and during acute bleeding events.
How does damoctocog alfa pegol work?+
Damoctocog alfa pegol supplies functional factor VIII, which restores the intrinsic pathway of the coagulation cascade. This enables proper thrombin generation and fibrin clot formation, correcting the clotting deficiency seen in hemophilia A.
What is the usual dose of Jivi?+
The dose of Jivi is individualized and must be prescribed by a qualified healthcare professional. The prescriber determines the amount and frequency based on the patient’s weight, severity of hemophilia, and clinical situation.
Is Jivi safe to use during pregnancy or breastfeeding?+
The safety of Jivi in pregnancy and lactation has not been fully established. Use should be considered only if the potential benefit justifies any potential risk to the mother or infant, and decisions are made by the treating physician.
How do I order Jivi from GNH USA?+
To order Jivi, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and import documentation.
How does Jivi compare with other factor VIII products?+
Jivi is a PEGylated recombinant factor VIII, offering an extended half‑life compared with standard factor VIII concentrates. This allows less frequent dosing for prophylaxis while maintaining comparable efficacy and safety profiles.
What are the storage and handling requirements for Jivi?+
Jivi must be stored refrigerated at 2‑8 °C, protected from light. Do not freeze or shake the vial. If the product must be transported, maintain the cold chain using validated insulated containers.
How is Jivi administered?+
Jivi is given as an intravenous infusion. The solution for injection is administered by a healthcare professional using aseptic technique, typically through a peripheral or central venous line, according to the prescriber’s instructions.
What are the most serious risks associated with Jivi?+
The most serious risks include the development of inhibitory antibodies against factor VIII, which can reduce efficacy, and rare severe hypersensitivity reactions such as anaphylaxis. Monitoring for these events is essential during treatment.
Who should not use Jivi?+
Jivi should not be used in patients with known hypersensitivity to damoctocog alfa pegol or any of its excipients. It is also contraindicated in individuals who have previously developed severe allergic reactions to factor VIII products.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Damoctocog Alfa Pegol
Route
Intravenous Use
Manufacturer
Bayer Ag
Origin
EU

Related products

Jivi

Jivi

Damoctocog Alfa Pegol

Bayer Ag
EU
Jivi

Jivi

Damoctocog Alfa Pegol

Bayer Ag
EU
Jivi

Jivi

Damoctocog Alfa Pegol

Bayer Ag
EU